TFPI2 Protein Boosts NK Cell Attack on Glioblastoma via Dual Mechanism
Glioblastoma remains one of the most treatment-resistant cancers, with median survival under 15 months even with aggressive therapy. A newly identified…
Found 2031 results for "cancer"
Glioblastoma remains one of the most treatment-resistant cancers, with median survival under 15 months even with aggressive therapy. A newly identified…
Most adults assume cancer appears suddenly, but mounting evidence reveals that certain blood cancers incubate silently for decades through a process called…
Brain metastases represent one of oncology's most intractable challenges — not because they are rare, but because even the best available interventions remain…
For men whose prostate cancer has become impervious to hormone therapy, treatment options narrow dramatically — and the molecular reasons why have remained…
Cancer treatment strategies built on destabilizing tumor chromosomes may be more complicated than previously assumed — and understanding why could reshape how…
As precision oncology increasingly captures headlines, a quieter revolution in cancer treatment is raising an urgent question that clinicians and payers alike…
For the millions of women with metastatic breast cancer, knowing whether a targeted therapy is actually reaching and killing tumor cells — in real time…
A computational re-examination of 45,454 gut microbiomes across 141 studies identified 15 microbial taxa simultaneously enriched in aging and depleted in…
Epigenetics rarely generates headlines outside specialist circles, yet this particular discovery touches something with direct health relevance: the molecular…
Understanding what actually executes p53's tumor-suppressing and aging-related commands inside living organisms—not just in cell cultures—has been one of…
Every cell in the human body depends on microscopic protein highways called microtubules to move cargo, divide chromosomes, and generate mechanical force…
The assumption that rapid long-range electrical signaling is exclusive to neurons may need fundamental revision. Evidence that ordinary skin and tissue lining…
As blood cancer survival rates climb, a critical and underappreciated threat is emerging in the decades that follow remission: cardiovascular disease. For the…
For the roughly 18 million cancer survivors in the United States alone, crossing the finish line of active treatment is not the end of the health story — it…
Young adults diagnosed with fibrolamellar carcinoma face a frustrating paradox: their tumors carry a highly recognizable oncogenic signature, yet the immune…
Cancer survival rates have improved dramatically over recent decades, yet the conversation about what survival actually looks like for patients—physically…
For adults navigating pancreatic disease, liver conditions, or gastrointestinal cancers, the tools physicians use to detect and characterize disease are…
For every individual who suspects a hereditary cancer risk, there are likely many more carrying actionable germline variants who were never referred for…
For the millions of adults who routinely consume zero-calorie sweeteners while managing weight or blood sugar, the assumption that sucralose is biologically…
Two of oncology's most formidable diagnoses may be entering a new era — not through a single breakthrough, but through the convergence of molecular profiling…